[Impaired fibrinolytic response to the venous occlusion test in patients with cryptogenic colitis]. 1991

J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
Laboratoire d'Hématologie et Immunologie, CHRU, Nîmes.

The fibrinolytic response to venous occlusion was studied in 17 patients with inflammatory bowel disease: 7 with Crohn's disease, 10 with ulcerative colitis and compared with those obtained in 20 controls. Patients with inflammatory bowel disease showed decreased tissue-type plasminogen activator antigen release (t-PA Ag), no significant Von Willebrand antigen release (vWF Ag), and a residual plasminogen activator inhibitor activity (PAI activity) after venous occlusion. These modifications were more important in the evolutive colitis group compared with the remission group. Hypofibrinolysis, as defined by a defective t-PA release, and a residual PAI activity after venous occlusion might contribute to digestive and/or extra digestive thrombotic manifestations observed during the course of inflammatory bowel diseases.

UI MeSH Term Description Entries
D008297 Male Males
D010960 Plasminogen Activators A heterogeneous group of proteolytic enzymes that convert PLASMINOGEN to FIBRINOLYSIN. They are concentrated in the lysosomes of most cells and in the vascular endothelium, particularly in the vessels of the microcirculation. Extrinsic Plasminogen Activators,Plasminogen Activator,Uterine-Tissue Plasminogen Activator,Uterine Tissue Plasminogen Activator
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor

Related Publications

J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
May 1976, Thrombosis research,
J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
September 1999, Thrombosis and haemostasis,
J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
January 1981, Thrombosis research,
J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
October 1997, Hematology and cell therapy,
J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
September 1975, British medical journal,
J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
February 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
January 1989, The Korean journal of internal medicine,
J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
February 2003, Pediatric research,
J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
March 1995, Thrombosis and haemostasis,
J C Gris, and J F Schved, and C Raffanel, and A Dubois, and D Ribard, and J L Balmes
November 1991, Thrombosis research,
Copied contents to your clipboard!